The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Journal:
Current Clinical Pharmacology
Volume:
8
Page:
135-155
Author(s):
Philipp Y. Maximov, Theresa M. Lee and V. Craig Jordan
RNAi in Clinical Studies
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1801-1816
Author(s):
P. Kubowicz, D. Zelaszczyk and E. Pekala
Bisacylimidoselenocarbamates Cause G2/M Arrest Associated with the Modulation of CDK1 and Chk2 in Human Breast Cancer MCF-7 Cells
Journal:
Current Medicinal Chemistry
Volume:
20
Page:
1609-1619
Author(s):
Iranzu Lamberto, Daniel Plano, Esther Moreno, Maria Font, Juan Antonio Palop, Carmen Sanmartin and Ignacio Encio
Current Status and Future Perspectives of PI3K and mTOR Inhibitor as Anticancer Drugs in Breast Cancer
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
175-187
Author(s):
Xiaobei Zhang, Xi-ru Li and Jin Zhang
Studies of NVP-BEZ235 in Melanoma
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
165-174
Author(s):
Joshua A. Sznol, Lucia B. Jilaveanu and Harriet M. Kluger
The miR-183/96/182 Cluster Regulates Oxidative Apoptosis and Sensitizes Cells to Chemotherapy in Gliomas
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
221-231
Author(s):
Hailin Tang, Yanhui Bian, Chaofeng Tu, Zeyou Wang, Zhibin Yu, Qing Liu, Gang Xu, Minghua Wu and Guiyuan Li
Roles of EGFR, PI3K, AKT, and mTOR in Heavy Metal-Induced Cancer
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
252-266
Author(s):
Richard L. Carpenter and Bing-Hua Jiang
Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?
Journal:
Current Cancer Drug Targets
Volume:
13
Page:
313-325
Author(s):
Matteo Santoni, Mimma Rizzo, Luciano Burattini, Rossana Berardi, Giacomo Carteni and Stefano Cascinu
Marine Natural Products and Related Compounds as Anticancer Agents: an Overview of their Clinical Status
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
13
Page:
603-631
Author(s):
Karina Petit and Jean-Francois Biard
Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
13
Page:
530-540
Author(s):
Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T. R. Bhardwaj